IGF2BP2 抗体
Quick Overview for IGF2BP2 抗体 (ABIN7452649)
抗原
See all IGF2BP2 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
- 
    - 
                                            原理
- Mouse anti-IGF2BP2 Monoclonal Antibody, Purified [1E3.01E5]
- 
                                            纯化方法
- Purified
- 
                                            免疫原
- Full length recombinant human protein IGF mRNA-binding protein 2
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- 
                        IP: 20 μL/mg lysate WB: 17:40:00 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            浓度
- 40 μg/mL
- 
                                            缓冲液
- Tris-buffered Saline containing 0.1 % BSA and 0.09 % Sodium Azide
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- 4 °C
- 
                                            有效期
- 12 months
 
- 
                                            
- 
    - IGF2BP2 (Insulin-Like Growth Factor 2 mRNA Binding Protein 2 (IGF2BP2))
- 
                                            别名
- IGF2BP2
- 
                                            背景
- Background: Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) binds to the 5'-UTR of the insulin-like growth factor 2 (IGF2) mRNAs. Binding is isoform-specific and may regulate translation of target mRNAs [taken from the Universal Protein Resource (UniProt) Q9Y6M1].
- 
                                            基因ID
- 10644
- 
                                            NCBI登录号
- NP_001007226
- 
                                            UniProt
- Q9Y6M1
 抗原
- 
                    
 
                                     
                                     
                                    